Sarah Edaily
Amman, AM, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country.
Journal: ImmunoTargets and therapy
Published: July 16, 2024
Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities.
Journal: Frontiers in oncology
Published: May 13, 2024
Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.
Journal: Scientific reports
Published: November 10, 2023
Prevalence, Patterns, and Predictors of Venous Thromboembolic Events in Patients Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Lymphomas.
Journal: Hematology/oncology and stem cell therapy
Published: June 26, 2023
Delays in Initiating Anti-Cancer Therapy for Early-Stage Breast Cancer-How Slow Can We Go?
Journal: Journal of clinical medicine
Published: May 18, 2023
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
Journal: Breast cancer (Dove Medical Press)
Published: October 31, 2022
Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.
Journal: Clinical interventions in aging
Published: June 28, 2022
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants.
Journal: OncoTargets and therapy
Published: April 07, 2022
Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review.
Journal: Annals of medicine and surgery (2012)
Published: January 28, 2022
Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.
Journal: Cancer management and research
Published: December 11, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026